Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma Kennedy
Observed names:
E. Kennedy,
Emma Kennedy (10950165),
Kennedy, Emma
Institution:
Brighton and Sussex Medical School
Observed institutions:
Brighton and Sussex Medical School,
University of London,
Royal Veterinary College,
Johns Hopkins University,
University of Sussex,
Loyola University Maryland,
University of Brighton
show all 7
ORCID:
0000-0002-6469-1109
Observed ORCID:
0000-0002-6469-1109
OpenAlex ID:
A5102790195
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target
2021
·
Emma Kennedy
, Eve Coulter
, et al.
·
Blood
·
47
PDF
Manipulating the 3D organization of the largest synthetic yeast chromosome
2023
·
Weimin Zhang
, Luciana Lazar-Stefanita
, et al.
·
Molecular Cell
·
43
PDF
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
2022
·
Thomas A. Burley
, Emma Kennedy
, et al.
·
Cancers
·
18
PDF
Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
2022
·
Thomas A. Burley
, Andrew Hesketh
, et al.
·
Cancers
·
12
PDF
NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
2023
·
Eleanor Jayawant
, Arran Pack
, et al.
·
Frontiers in Oncology
·
9
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL
2025
·
Aimilia Vareli
, Haripriya Vaidehi Narayanan
, et al.
·
Cell Death and Disease
·
7
PDF
The 18 kDa Translocator Protein (TSPO): Cholesterol Trafficking and the Biology of a Prognostic and Therapeutic Mitochondrial Target
2017
·
Michele Frison
, Anna Katherina Mallach
, et al.
·
Biological and medical physics, biomedical engineering
·
5
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance
2025
·
Eleni Ε. Ladikou
, Kim Sharp
, et al.
·
Cancers
·
4
PDF
TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.
2026
·
Emma Kennedy
, Lauren Stott
, et al.
·
Blood
PDF
Evaluation of greatwall kinase inhibition as a potential therapeutic strategy in CLL and DLBCL.
2025
·
Elaina Pasangha
, Lauren Stott
, et al.
·
Blood
Training Students to be Highly Employable, Professional Chemists
2024
·
Rogers, Michael
, Walker, Sarah
, et al.
·
Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)
PDF
P418: Modelling and Targeting Acute Myeloid Leukaemia Cells in the Bone Marrow Protective Niche
2022
·
E. E. Ladikou
, K. Sharp
, et al.
·
HemaSphere
P613: Tlr9 Signalling Is a Potential Tumour Escape Mechanism Following Btki Therapy for the Treatment of Chronic Lymphocytic Leukaemia.
2022
·
E. Kennedy
, S. Mitchell
, et al.
·
HemaSphere
Pb1788: Low Expression of C-type Lectin-like Molecule-1 and Reduced Oxidative Stress Define a Subset of Acute Myeloid Leukaemia Cells With ‘stem-like’ Properties
2022
·
K. Sharp
, E. Ladikou
, et al.
·
HemaSphere
Show more works
View as search
Works count:
15
Citation count:
145
H-index:
6
I10-index:
4
Year
Topic
Type